Skip to main content

Paul

Head of Investor Relations

Immunic, Inc. (IMUX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Immunic, Inc. publishes a filing, an earnings call transcript or a press release.

Get IMUX alerts

About Paul

Paul is recorded as Head of Investor Relations at Immunic, Inc. (IMUX). Paul has spoken on 1 investor event across 1 company, most recently for Immunic, Inc. on November 10, 2026. Immunic, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunic, Inc. includes Dr. Daniel Vitt (CEO), Duane D. Nash (CEO), Duane Nash (CEO) and 7 others.

Paul on recent calls

“Happy to be moderating this chat here with the Munich management team. With me is Eric Lundgren and Jason Tardio. These guys have a somewhat important clinical readout coming up, maybe.”
Head of Investor Relations, Stifel 2026 Healthcare Conference ·

Affiliation history

Company network

Leadership on record at Immunic, Inc.

Recent activity